Abstract
The mechanism of action of the immunosuppressive drug, cyclosporin A (CyA), was analyzed with respect to antigen-induced production of the human lymphokine, leukocyte migration inhibitory factor (LIF). Mononuclear cells as well as purified T-cells did not elaborate LIF in the presence of pharmacological concentrations of CyA. CyA-induced immunosuppression was competitively reversed by addition of the partially purified monokines, T-cell-activating factor (TAF) and lymphocyte-activating factor (LAF). CyA did not affect T-cell priming with antigens. The drug failed to abolish LIF production if added 60 min after challenge of T-cells with recall antigen in the presence of TAF. Furthermore, addition of TAF within 15 min to CyA-treated T-cells resulted in unaltered LIF production. These results suggest that CyA suppresses the early stage of the immune response by competing with the function of TAF/LAF on the immune T-cell.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
